TrialEuropean radiology2023

Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.

Minjae Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.